StockLens

NATCO Pharma Limited (NATCOPHARM) share price and analysis

NATCOPHARM last traded at ₹822.90 (-0.69%) on the NSE. Market cap ₹16,143 Cr (Small cap), Pharma & Healthcare sector.

Overall rating: 6.2/10 (Average)

Long-term view: Neutral (watchlist). A mixed picture. Wait for better value or a clearer trend. Trade bias (next few weeks): Strong short. Trend and momentum are clearly pointing down.

Strengths of NATCOPHARM

Weaknesses of NATCOPHARM

Key numbers

NumberValueAssessmentNormal range
P/E (TTM)17.9Cheaper than peers37.0–49.3 (sector median 41.1)
Forward P/E17.5Profits expected flatbelow today's P/E (17.9) and near 41
Price / book1.60Low2–6
EPS (TTM)₹45.89Profitableabove ₹0
Return on equity–15%+ (below 10% is weak)
Debt / equity0.08Low debtbelow 1.0 (under 0.5 is great)
Net margin32.8%Healthy10%+ (below 5% is thin)
Operating margin24.6%Strong20%+ strong, below 10% thin
Revenue growth-44.7%Shrinking10%+ a year (below 3% is weak)
Profit growth-57.0%Falling10%+ a year (falling is weak)
Dividend yield0.73%Small payout1.5%+ (none is fine for growth firms)
Current ratio–1.5+ (below 1 is tight)
52W high₹1,226.8033% below · far from the highprice in the top 40% of its 52-week range
52W low₹773.60Price is 6% above it
50-DMA₹808.16Price 1.8% aboveprice above it = short-term uptrend
200-DMA₹926.00Price 11.1% belowprice above it = long-term uptrend
1Y return+3.0%In line with Nifty 50Nifty 50 did −0.4%
Beta0.18Steadier than the market0.8–1.3 (1 = moves with market)
Promoter / insider47.6%Moderate stake50%+ shows owner commitment
Institutions15.7%Moderate interest30%+ is strong
Analyst target₹1,002.1121.8% upside · 9 analysts8%+ upside

Questions about NATCOPHARM

What is the share price of NATCO Pharma Limited (NATCOPHARM) today?

NATCOPHARM last traded at ₹822.90 (-0.69% on the day) on the NSE. Its 52-week range is ₹773.60 to ₹1,226.80. Prices are delayed and come from Yahoo Finance.

Is NATCOPHARM a good stock for the long term?

StockLens rates NATCOPHARM 6.2 out of 10 (Average) overall. Its long-term verdict is "Neutral (watchlist)": A mixed picture. Wait for better value or a clearer trend. Strengths: cheap vs peers, low debt, high margins. Concerns: downtrend, shrinking revenue, falling profits.

Is NATCOPHARM share overvalued?

NATCOPHARM trades at a P/E of 17.9 against a Pharma & Healthcare median of 41.1, which StockLens rates as "Cheaper than peers". Its price-to-book ratio is 1.60.

Is NATCOPHARM good for short-term trading?

The trade bias for the next few weeks is "Strong short": Trend and momentum are clearly pointing down. The price is 11.1% below its 200-day average and 14-day RSI is 61.

Which stocks are similar to NATCOPHARM?

Similar Pharma & Healthcare stocks of comparable size include Granules India, Biocon, Alkem Laboratories, Glenmark Pharmaceuticals, Lupin. You can compare up to 4 of them side by side on StockLens.

About NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Agrochemicals. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, fungicides, herbicides, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Stocks similar to NATCOPHARM

Compare NATCOPHARM with GRANULES, BIOCON, ALKEM

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.